1 Introduction to Research & Analysis Reports 1.1 Cytomegalovirus Retinitis Treatment Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Cytomegalovirus Retinitis Treatment Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Cytomegalovirus Retinitis Treatment Overall Market Size 2.1 China Cytomegalovirus Retinitis Treatment Market Size: 2021 VS 2027 2.2 China Cytomegalovirus Retinitis Treatment Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Cytomegalovirus Retinitis Treatment Players in China Market 3.2 Top China Cytomegalovirus Retinitis Treatment Companies Ranked by Revenue 3.3 China Cytomegalovirus Retinitis Treatment Revenue by Companies 3.4 Top 3 and Top 5 Cytomegalovirus Retinitis Treatment Companies in China Market, by Revenue in 2020 3.5 Companies Cytomegalovirus Retinitis Treatment Product Type 3.6 Tier 1, Tier 2 and Tier 3 Cytomegalovirus Retinitis Treatment Players in China Market 3.6.1 List of Tier 1 Cytomegalovirus Retinitis Treatment Companies in China 3.6.2 List of Tier 2 and Tier 3 Cytomegalovirus Retinitis Treatment Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Cytomegalovirus Retinitis Treatment Market Size Markets, 2021 & 2027 4.1.2 Capsules 4.1.3 Solutions 4.1.4 Implants 4.1.5 Tablets 4.2 By Type - China Cytomegalovirus Retinitis Treatment Revenue & Forecasts 4.2.1 By Type - China Cytomegalovirus Retinitis Treatment Revenue, 2016-2021 4.2.2 By Type - China Cytomegalovirus Retinitis Treatment Revenue, 2022-2027 4.2.3 By Type - China Cytomegalovirus Retinitis Treatment Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Cytomegalovirus Retinitis Treatment Market Size, 2021 & 2027 5.1.2 Hospitals 5.1.3 Ambulatory Surgical Centers 5.1.4 Others 5.2 By Application - China Cytomegalovirus Retinitis Treatment Revenue & Forecasts 5.2.1 By Application - China Cytomegalovirus Retinitis Treatment Revenue, 2016-2021 5.2.2 By Application - China Cytomegalovirus Retinitis Treatment Revenue, 2022-2027 5.2.3 By Application - China Cytomegalovirus Retinitis Treatment Revenue Market Share, 2016-2027 6 Cytomegalovirus Retinitis Treatment Companies Profiles 6.1 Roche 6.1.1 Roche Company Details 6.1.2 Roche Business Overview 6.1.3 Roche Cytomegalovirus Retinitis Treatment Introduction 6.1.4 Roche Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) 6.1.5 Roche Recent Developments 6.2 Gilead Sciences 6.2.1 Gilead Sciences Company Details 6.2.2 Gilead Sciences Business Overview 6.2.3 Gilead Sciences Cytomegalovirus Retinitis Treatment Introduction 6.2.4 Gilead Sciences Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) 6.2.5 Gilead Sciences Recent Developments 6.3 Takeda 6.3.1 Takeda Company Details 6.3.2 Takeda Business Overview 6.3.3 Takeda Cytomegalovirus Retinitis Treatment Introduction 6.3.4 Takeda Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) 6.3.5 Takeda Recent Developments 6.4 Auritec 6.4.1 Auritec Company Details 6.4.2 Auritec Business Overview 6.4.3 Auritec Cytomegalovirus Retinitis Treatment Introduction 6.4.4 Auritec Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) 6.4.5 Auritec Recent Developments 6.5 Chimerix 6.5.1 Chimerix Company Details 6.5.2 Chimerix Business Overview 6.5.3 Chimerix Cytomegalovirus Retinitis Treatment Introduction 6.5.4 Chimerix Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) 6.5.5 Chimerix Recent Developments 6.6 Isis 6.6.1 Isis Company Details 6.6.2 Isis Business Overview 6.6.3 Isis Cytomegalovirus Retinitis Treatment Introduction 6.6.4 Isis Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) 6.6.5 Isis Recent Developments 6.7 PSivida 6.7.1 PSivida Company Details 6.7.2 PSivida Business Overview 6.7.3 PSivida Cytomegalovirus Retinitis Treatment Introduction 6.7.4 PSivida Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) 6.7.5 PSivida Recent Developments 6.8 Sanofi 6.8.1 Sanofi Company Details 6.8.2 Sanofi Business Overview 6.8.3 Sanofi Cytomegalovirus Retinitis Treatment Introduction 6.8.4 Sanofi Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) 6.8.5 Sanofi Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Cytomegalovirus Retinitis Treatment Market Opportunities & Trends in China Market Table 2. Cytomegalovirus Retinitis Treatment Market Drivers in China Market Table 3. Cytomegalovirus Retinitis Treatment Market Restraints in China Market Table 4. Key Players of Cytomegalovirus Retinitis Treatment in China Market Table 5. Top Cytomegalovirus Retinitis Treatment Players in China Market, Ranking by Revenue (2019) Table 6. China Cytomegalovirus Retinitis Treatment Revenue by Companies, (US$, Mn), 2016-2021 Table 7. China Cytomegalovirus Retinitis Treatment Revenue Share by Companies, 2016-2021 Table 8. Companies Cytomegalovirus Retinitis Treatment Product Type Table 9. List of Tier 1 Cytomegalovirus Retinitis Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Cytomegalovirus Retinitis Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – China Cytomegalovirus Retinitis Treatment Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - China Cytomegalovirus Retinitis Treatment Revenue (US$, Mn), 2016-2021 Table 13. By Type - China Cytomegalovirus Retinitis Treatment Revenue (US$, Mn), 2022-2027 Table 14. By Application – China Cytomegalovirus Retinitis Treatment Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - China Cytomegalovirus Retinitis Treatment Revenue (US$, Mn), 2016-2021 Table 16. By Application - China Cytomegalovirus Retinitis Treatment Revenue (US$, Mn), 2022-2027 Table 17. Roche Company Details Table 18. Roche Business Overview Table 19. Roche Cytomegalovirus Retinitis Treatment Product Table 20. Roche Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 21. Roche Recent Developments Table 22. Gilead Sciences Company Details Table 23. Gilead Sciences Business Overview Table 24. Gilead Sciences Cytomegalovirus Retinitis Treatment Product Table 25. Gilead Sciences Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 26. Gilead Sciences Recent Developments Table 27. Takeda Company Details Table 28. Takeda Business Overview Table 29. Takeda Cytomegalovirus Retinitis Treatment Product Table 30. Takeda Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 31. Takeda Recent Developments Table 32. Auritec Company Details Table 33. Auritec Business Overview Table 34. Auritec Cytomegalovirus Retinitis Treatment Product Table 35. Auritec Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 36. Auritec Recent Developments Table 37. Chimerix Company Details Table 38. Chimerix Business Overview Table 39. Chimerix Cytomegalovirus Retinitis Treatment Product Table 40. Chimerix Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 41. Chimerix Recent Developments Table 42. Isis Company Details Table 43. Isis Business Overview Table 44. Isis Cytomegalovirus Retinitis Treatment Product Table 45. Isis Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 46. Isis Recent Developments Table 47. PSivida Company Details Table 48. PSivida Business Overview Table 49. PSivida Cytomegalovirus Retinitis Treatment Product Table 50. PSivida Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 51. PSivida Recent Developments Table 52. Sanofi Company Details Table 53. Sanofi Business Overview Table 54. Sanofi Cytomegalovirus Retinitis Treatment Product Table 55. Sanofi Cytomegalovirus Retinitis Treatment Revenue in China Market (2016-2021) & (US$ Million) Table 56. Sanofi Recent Developments List of Figures Figure 1. Cytomegalovirus Retinitis Treatment Segment by Type Figure 2. Cytomegalovirus Retinitis Treatment Segment by Application Figure 3. China Cytomegalovirus Retinitis Treatment Market Overview: 2020 Figure 4. China Cytomegalovirus Retinitis Treatment Market Size: 2021 VS 2027 (US$, Mn) Figure 5. China Cytomegalovirus Retinitis Treatment Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Cytomegalovirus Retinitis Treatment Revenue in 2020 Figure 7. By Type - China Cytomegalovirus Retinitis Treatment Revenue Market Share, 2016-2027 Figure 8. By Application - China Cytomegalovirus Retinitis Treatment Revenue Market Share, 2016-2027 Figure 9. Roche Cytomegalovirus Retinitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Gilead Sciences Cytomegalovirus Retinitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Takeda Cytomegalovirus Retinitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Auritec Cytomegalovirus Retinitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Chimerix Cytomegalovirus Retinitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Isis Cytomegalovirus Retinitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. PSivida Cytomegalovirus Retinitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. Sanofi Cytomegalovirus Retinitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Roche Gilead Sciences Takeda Auritec Chimerix Isis PSivida Sanofi